Document And Entity Information |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Document Information Line Items | |
| Entity Central Index Key | 0001840877 |
| Document Type | POS AM |
| Entity Registrant Name | Envoy Medical, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity Filer Category | Non-accelerated Filer |
| Entity Small Business | true |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Amendment Description | This Post-Effective Amendment No. 1 (this “Post-Effective Amendment”) to the Registration Statement on Form S-1 (File No. 333-290927) (the “Registration Statement”), as originally filed on October 17, 2025 and declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on December 30, 2025, is being filed to include information contained in the registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on March 23, 2026, and to update certain other information in the Registration Statement.The information included in this filing amends the Registration Statement and the prospectus contained therein. No additional securities are being registered under this Post-Effective Amendment. All applicable registration fees were paid at the time of the original filing of the Registration Statement on October 17, 2025. |
| Amendment Flag | true |